Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Bright nanoparticle probes for amplified fluorescence in situ hybridization in cancer diagnostics

Project description

Nanotechnology brings cancer diagnostics to the next era

Fluorescence in situ hybridisation (FISH) is a well-established method for the detection of nucleic acids in cells using fluorescent probes. However, FISH application in cancer diagnostics is limited due to the slow turnaround of results, the high cost and the complexity of the protocol. To address this, the EU-funded AmpliFISH project is working on novel probes based on nanoparticles. These FISH nanoprobes will exhibit single-molecule DNA/RNA sensitivity, owing to their 1 000-fold higher brightness than traditional probes, and they will be more economical and simple to use. AmpliFISH probes will be specially designed for cancer research and clinical diagnostics offering the capacity for the simultaneous detection up to nine biomarkers in a single assay.

Objective

Rapidly expanding field of cancer diagnostics generates strong demand for new biosensing tools. In particular, it concerns probes for fluorescence in situ hybridization (FISH), that enables detection of DNA and RNA cancer biomarkers directly in diseased cells. Although FISH technique has already been accepted for cancer diagnostics in clinics, its applications are still limited because the method is slow, expensive and requires complicated amplification protocols to obtain sufficient fluorescence signal. Here, we propose a solution based on ultrabright DNA-functionalized dye-loaded fluorescent polymeric nanoparticles recently developed within the ERC grant BrightSens and protected by two patent applications. We aim to develop ultrabright FISH probes (nanoprobes) for cancer research and clinical diagnostics. These nanoprobes will feature single-molecule DNA/RNA sensitivity, low cost, fast and direct one step cell staining protocol, and compatibility with clinical samples and single-cell assays. The amplification of FISH performance will be ensured by our dye-loaded polymeric nanoparticles of 7-20 nm size that are ~1000 fold brighter than single organic dyes. The project is composed of five tasks: (1) Synthesis and optimization of FISH nanoprobes; (2) validation of FISH nanoprobes in cancer cell lines; (3) development of multiplexing assays for detection at least 9 biomarkers; (4) their validation in clinically relevant samples; and, finally, (5) commercialization of FISH nanoprobes. The developed probes will constitute highly competitive products that can greatly improve performance of FISH assays in clinics and research laboratories and thus impact human health. Therefore, they will be directly proposed for commercialization by licensing to existing companies and/or through creation of a startup.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-POC - Proof of Concept Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2019-PoC

See all projects funded under this call

Host institution

UNIVERSITE DE STRASBOURG
Net EU contribution
€ 150 000,00
Address
RUE BLAISE PASCAL 4
67081 Strasbourg
France
Region
Grand Est Alsace Bas-Rhin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)